To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
-
Oligomeric Alpha-Synuclein Protein*
Stable oligomeric aggregates of alpha-synuclein protein. Intended for use in biochemical assays (not intended for use in the pre-formed fibril model).
-
Parkin/PINK1 Double KO Rat
Knockout of Parkin and PINK1 in the Long Evans Hooded rat strain.
-
Halo-Tagged LRRK2 MEF
Mouse embryonic fibroblast line with knockin of the Halo tag on the N-terminal of LRRK2.
Expected availability: Late 2024
-
LRRK2 R1441G KI MEF
Mouse embryonic fibroblast line with knockin of the LRRK2 R1441G mutation.
Expected availability: Late 2024
-
LRRK2 G2019S KI MEF
Mouse embryonic fibroblast line with knockin of the LRRK2 G2019S mutation.
Expected availability: Late 2024
-
LRRK2 KO MEF
Mouse embryonic fibroblast line with knockout of LRRK2.
Expected availability: Late 2024
-
SNCA Multiplication iPSC Lines*
Isogenic iPSC lines harboring a triplication , duplication, single copy, or KO of the SNCA gene derived from a patient with the triplication mutation. These lines were generated and kindly deposited by Birgitt Schuele at Stanford University into the MJFF Sponsored Tools Program.
-
Rab 3 pT86 Phosphospecific Antibody
Rabbit monoclonal phosphospecific antibody directed against Threonine86 of Rab3. Suitable for immunoblot applications.
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic